PLX Stock Summary and Trading Ideas (Protalix Biotherapeutics (De) | AMEX:PLX)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

What symbol and exchange does Protalix Biotherapeutics (De) shares trade?

Protalix Biotherapeutics (De) trades on the AMEX stock market under the symbol PLX.

What is Protalix Biotherapeutics (De) stock price doing today?

As of October 13, 2026, PLX stock price declined to $2.75 with 953,316 million shares trading.

What is Protalix Biotherapeutics (De)'s Beta?

PLX has a beta of 1.14, meaning it tends to be more sensitive to market movements. PLX has a correlation of 0.05 to the broad based SPY ETF.

How much is Protalix Biotherapeutics (De) worth?

PLX has a market cap of $221.57 million. This is considered a Small Cap stock.

How much money does Protalix Biotherapeutics (De) make?

Last quarter Protalix Biotherapeutics (De) reported $20 million in Revenue and $.05 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.06.

What is the highest and lowest price Protalix Biotherapeutics (De) traded in the last 3 year period?

In the last 3 years, PLX traded as high as $3.19 and as low as $.82.

What are the top ETFs holding Protalix Biotherapeutics (De)?

The top ETF exchange traded funds that PLX belongs to (by Net Assets): IWM, IWO, VTWO, IWC, DFAS.

Is Protalix Biotherapeutics (De) (PLX) a good investment?

PLX has underperformed the market in the last year with a return of +16.5%, while SPY returned +18.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PLX shares. However, PLX has outperformed the market in the last 3 month and 2 week periods, returning +12.7% and +2.2%, while SPY returned +4.1% and +1.8%, respectively. This indicates PLX has been having a stronger performance recently.

What are the support and resistance levels for Protalix Biotherapeutics (De) (PLX)?

PLX support price is $2.72 and resistance is $2.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLX shares will trade within this expected range on the day.